CalciMedica Files Proxy Materials

Ticker: CALC · Form: DEFA14A · Filed: Jun 9, 2025 · CIK: 1534133

Calcimedica, INC. DEFA14A Filing Summary
FieldDetail
CompanyCalcimedica, INC. (CALC)
Form TypeDEFA14A
Filed DateJun 9, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: proxy-filing, corporate-governance, pharmaceuticals

TL;DR

CalciMedica dropped proxy docs, likely for shareholder votes. Standard stuff.

AI Summary

CalciMedica, Inc. filed a Definitive Additional Materials proxy statement on June 9, 2025. This filing relates to the company's proxy materials, which are typically used for shareholder meetings to vote on corporate matters. The company, formerly known as Graybug Vision, Inc., is incorporated in Delaware and operates in the pharmaceutical preparations sector.

Why It Matters

This filing indicates that CalciMedica is engaging with its shareholders regarding corporate governance and voting matters, which is a standard but important part of public company operations.

Risk Assessment

Risk Level: low — This is a routine proxy filing, not indicating any immediate financial or operational distress.

Key Players & Entities

FAQ

What type of filing is this DEFA14A for CalciMedica, Inc.?

This is a Definitive Additional Materials filing, indicated by the checkmark next to 'Definitive Additional Materials' and the form type DEFA14A.

When was this filing made?

The filing was made on June 9, 2025.

What is CalciMedica, Inc.'s Standard Industrial Classification code?

CalciMedica, Inc.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.

Has CalciMedica, Inc. always been known by this name?

No, the company was formerly known as Graybug Vision, Inc. and prior to that, Graybug, Inc.

Where is CalciMedica, Inc. located?

CalciMedica, Inc. is located at 505 Coast Boulevard South, Suite 307, La Jolla, CA 92037.

Filing Details

This Form DEFA14A (Form DEFA14A) was filed with the SEC on June 9, 2025 regarding CalciMedica, Inc. (CALC).

View full filing on EDGAR

View Full Filing

View this DEFA14A filing on SEC EDGAR

View on Read The Filing